Why Asahi Kasei Pharma Chose Pandatron for Their Multi-Continental Merger
No Surveys, No Delays, Less Biases
When the Clinical Development Center at Asahi Kasei Pharma faced a complex multi-continental merger, they needed more than traditional change management — they needed real-time intelligence on employee sentiment across cultures. Pandatron delivered what most M&A consultants can't: a scalable AI coaching platform that simultaneously supported employees through uncertainty while surfacing critical integration issues before they became crises.
- →Identified language barriers hindering collaboration
- →Mapped its cultural DNA to gain clarity on potential future roadblocks
- →Moved employees out of the 'change resistant' category
- →Added targeted coaching tracks based on insights from monthly Change Confidence Index tracking
- →Transformed anxiety into actionable plans
- →Enabled employees to take accountability for their own transformation journey
At the end of the trial, 62.5% of users expressed a desire to continue with Panda, and the program continues today.
Pandatron's systemic AI coaching operates in the flow of work, combining personalized guidance with aggregated analytics that reveal organizational patterns invisible to traditional methods. Each conversation deepens individual capability while feeding anonymized insights back to leadership — no surveys, no delays and a possibility to reduce bias.
The platform's long-term memory ensures context isn't lost between sessions, while its judgment-free space encourages employees to surface the real issues: structural misalignments, cross-cultural feedback challenges, and career advancement concerns that would never make it into a traditional town hall event.
The strategic value wasn't just in coaching — it was in dual-layer intelligence. While employees gain confidence in cross-cultural communication and reframe concerns into growth opportunities, leadership receives unprecedented visibility into integration risks and psychological safety gaps. Pandatron proves that in complex M&As, such as this, People Insights contribute to visualizing integration risks.
No resistance was observed in the coaching conversations, reinforcing the trust employees placed in the platform and validating the effectiveness of an AI-enabled, psychologically safe space embedded directly into daily work.
At the end of the trial, 62.5% of users expressed a desire to continue with Panda, and the program continues today.
Including identifying language barriers, mapping cultural DNA, moving employees out of the change-resistant category, and transforming anxiety into actionable plans.
No resistance was observed in the coaching conversations, reinforcing the trust employees placed in the platform.
- →62.5% of trial users chose to continue — program is ongoing today
- →Language barriers identified and mapped across three continents
- →Employees moved out of the change resistant category during trial
- →Zero resistance observed across all coaching conversations
- →Leadership gained real-time visibility into integration risks without surveys
Working with Pandatron has been an exceptionally smooth experience. Their approach seamlessly integrates into employees' daily routines, supporting the Clinical Development Center within Asahi Kasei Pharma at both individual and departmental levels. This has enabled management to identify areas for improvement and strengthen confidence in the ongoing tri-continent merger.
Brendan · AKP · Clinical Development Center